How to reconstitute MOTS-c — visual step-by-step
A visual, step-by-step reconstitution protocol for MOTS-c mitochondrial peptide lyophilized research vials — covering materials, dose math for daily or periodic research schedules, and cold-chain storage. For research purposes only.
What is reconstitution and why it matters for MOTS-c
MOTS-c (Mitochondrial Open reading frame of the twelve S rRNA-c) is a 16-amino-acid peptide encoded in the mitochondrial genome. It has been studied for its roles in metabolic regulation, insulin sensitivity, exercise mimicry, and aging. Research vials ship as lyophilized powder, typically 5–10 mg. MOTS-c is a shorter, unmodified peptide compared to GLP-1 agonists, so it generally dissolves readily and does not require extended swirling. However, precise reconstitution is still essential because research doses are small (commonly 5–10 mg per injection in animal models; smaller in cell-based studies), and errors in concentration directly impact dose accuracy.
Internal links: see the MOTS-c peptide profile at /peptides/mots-c, the MOTS-c mechanism and dosing guide, and /methodology.
Materials required
Gather: (1) MOTS-c research vial — commonly 5 mg or 10 mg lyophilized powder. (2) Bacteriostatic water for injection, 30 mL multi-dose vial. (3) Two 1 mL U-100 insulin syringes. (4) Two 70% IPA alcohol swabs. (5) Clean, flat workspace. (6) Sharps disposal container. (7) Permanent marker and adhesive label.
Step-by-step reconstitution protocol
Step 1 — Verify materials (see Diagram 1)
Confirm the MOTS-c vial contains white lyophilized powder with no discoloration or moisture. Confirm the BAC water vial is clear and within its use-by date. Wash hands for 20 seconds.
Step 2 — Swab both septa
Swab the BAC water septum with 70% IPA in a single outward stroke. Allow to air-dry for 10–15 seconds. Repeat with a fresh swab on the MOTS-c vial. Do not touch the swabbed surfaces.
Step 3 — Draw bacteriostatic water (see Diagram 2)
Insert a fresh needle into the BAC water vial, invert, and draw the required volume. For a 5 mg MOTS-c vial: 1.0 mL gives 5,000 mcg/mL; 2.0 mL gives 2,500 mcg/mL. For a 10 mg vial: 2.0 mL gives 5,000 mcg/mL. Because MOTS-c research doses per injection are typically in the 5–10 mg range for in-vivo models (and may be adjusted for body weight), selecting 2.0 mL reconstitution for a 5 mg vial (2,500 mcg/mL) gives a dose draw volume that is manageable.
Step 4 — Introduce water against the glass wall (see Diagram 3)
Tilt the MOTS-c vial at 45 degrees. Insert the needle through the septum, directing the tip at the inner glass wall. Introduce the bacteriostatic water slowly along the wall. MOTS-c, as an unmodified short peptide, is less prone to aggregation than lipidated peptides, but the wall-directed technique is still best practice to avoid foam and mechanical disruption.
Step 5 — Gently swirl to dissolve
Roll the vial between your palms for 15–30 seconds. MOTS-c dissolves readily into a clear, colorless solution. Do not shake or vortex. Inspect: the solution should be free of particulates and cloudiness.
Step 6 — Label and store (see Diagram 4)
Label with peptide name, concentration, reconstitution date, and 28-day expiry. Refrigerate at 2–8°C. Do not freeze the reconstituted solution. If the entire reconstituted volume will not be used within 28 days, consider reconstituting smaller fractions to minimize waste.
Dose math: translating research doses to U-100 syringe units
Example — 5 mg vial in 2.0 mL BAC water: concentration = 2,500 mcg/mL = 25 mcg per unit on U-100. A 5 mg (5,000 mcg) dose = 200 units (2 full syringes). A 2.5 mg dose = 100 units (1 full syringe). A 1 mg dose = 40 units. For weight-adjusted dosing in animal research: determine dose in mcg/kg, multiply by subject weight (kg), then divide by concentration (mcg/mL) to get volume in mL, then convert to U-100 units (1 unit = 0.01 mL).
Storage post-reconstitution
Reconstituted MOTS-c in bacteriostatic water: refrigerate at 2–8°C for up to 28 days. Do not freeze. Protect from light. As a short, unmodified peptide, MOTS-c is generally stable under refrigeration for this period with benzyl alcohol present as a preservative.
Common mistakes to avoid
Frequently asked questions
- What is the mitochondrial origin of MOTS-c and why does it matter for research?
- MOTS-c is encoded within the 12S ribosomal RNA gene of the mitochondrial genome — making it distinct from nuclear-encoded peptides. This origin means it is released from mitochondria in response to metabolic stress and acts as a retrograde signal that influences nuclear gene expression related to AMPK activation, glucose metabolism, and exercise adaptation. For research, this means MOTS-c dosing and reconstitution precision directly affects the reproducibility of metabolic signaling readouts.
- Does MOTS-c dissolve quickly compared to lipidated peptides like semaglutide?
- Yes. MOTS-c is a 16-amino-acid peptide with no fatty acid modification. It dissolves readily in bacteriostatic water within 15–30 seconds of gentle rolling. You do not need to allow 2–3 minutes as with lipidated GLP-1 analogs. If the solution is not clear after 30 seconds, continue gently swirling for up to 1 minute before discarding.
- Can MOTS-c be administered subcutaneously in animal research models?
- Yes. Published animal model research has used subcutaneous injection as the primary route. Studies such as Lee et al. (Cell Metab, 2015) used subcutaneous MOTS-c administration in mouse models. Researchers should consult the specific published protocol for route, dose, and frequency parameters appropriate to their model.
- What is the typical in-vivo research dose range for MOTS-c?
- In the foundational Lee et al. 2015 study, daily subcutaneous doses of 15 mg/kg were used in mouse models for obesity/insulin resistance research. More recent studies have used a range of 5–30 mg/kg depending on the model and endpoint. Researchers must translate animal-model doses to their specific protocol using body-weight adjustment.
- Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID: 25738459. https://pubmed.ncbi.nlm.nih.gov/25738459/
- USP <797> Pharmaceutical Compounding — Sterile Preparations. https://www.usp.org/compounding/general-chapter-797
- FDA — Bacteriostatic Water for Injection USP prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016831Orig1s040lbl.pdf
Was this guide helpful?